James Brorson to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications James Brorson has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.636
-
Predictors of very early stroke recurrence in the POINT trial population. BMC Neurol. 2022 May 14; 22(1):177.
Score: 0.636
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.